Related references
Note: Only part of the references are listed.Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain
Gugan Kothandana et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
CSAR Benchmark Exercise of 2010: Combined Evaluation Across All Submitted Scoring Functions
Richard D. Smith et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
Tony Warne et al.
NATURE (2011)
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
Michael P. Bokoch et al.
NATURE (2010)
Determining receptor-ligand interaction of human galanin receptor type 3
Johan Runesson et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Achieving reliability and high accuracy in automated protein docking: ClusPro, PIPER, SOU, and stability analysis in CAPRI rounds 13-19
Dima Kozakov et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Galanin, galanin receptors and drug targets
K. Mitsukawa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Amino substituted analogs of 1-phenyl-3-phenylimino-2-indolones with potent galanin Gal3 receptor binding affinity and improved solubility
Michael J. Konkel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonists
Michael J. Konkel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299
CJ Swanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
G-protein-coupled receptor affinity prediction based on the use of a profiling dataset:: QSAR design, synthesis, and experimental validation
C Rolland et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Galnon -: a low-molecular weight ligand of the galanin receptors
U Sollenberg et al.
NEUROPEPTIDES (2005)
Important pharmacophores for binding to galanin receptor 2
L Lundström et al.
NEUROPEPTIDES (2005)
International Union of Pharmacology. XLVI. G protein-coupled receptor list
SM Foord et al.
PHARMACOLOGICAL REVIEWS (2005)
Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites
ATR Laurie et al.
BIOINFORMATICS (2005)
Galanin and galanin receptors in epilepsy
AM Mazarati
NEUROPEPTIDES (2004)
NMR solution structure and position of transportan in neutral phospholipid bicelles
E Bárány-Wallje et al.
FEBS LETTERS (2004)
Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus
A Mazarati et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Tools for comparative protein structure modeling and analysis
N Eswar et al.
NUCLEIC ACIDS RESEARCH (2003)
Anticonvulsant activity of a nonpeptide galanin receptor agonist
K Saar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Galanin receptor subtypes
TA Branchek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
